Abstract-Previous studies have implicated a role of Gα i proteins as co-regulators of Toll-like receptor (TLR) activation. These studies largely derived from examining the effect of Gα i protein inhibitors or genetic deletion of Gα i proteins. However, the effect of increased Gα i protein function or Gα i protein expression on TLR activation has not been investigated. We hypothesized that gain of function or increased expression of Gα i proteins suppresses TLR2-and TLR4-induced inflammatory cytokines. Novel transgenic mice with genomic "knock-in" of a regulator of G protein signaling (RGS)-insensitive Gnai2 allele (Gα i2
INTRODUCTION
Sepsis is the clinical manifestation of a systemic maladaptive host response to invasive infection. Sepsis leading to septic shock and multiple organ failure is the leading cause of death in intensive care units and remains a major health problem in the USA and worldwide [1, 2] . The interaction of bacterial components such as LPS, peptidoglycan, lipoteichoic acid, and exotoxins with macrophages, monocytes, endothelial cells or other host cells induces the release of inflammatory mediators that play a major role in the pathophysiology of septic shock [3, 4] .
The Toll-like receptor (TLR) family plays a critical role in mediating the innate and adaptive immune response [5] . The Gram-negative bacteria cell wall component LPS-induced signaling is mediated by TLR4 coupled with CD14 and MD-2 [6] . Lipoprotein from the Gram-positive bacteria-induced signaling pathways is mediated, in part, through TLR2 and other receptors [7] . Pam3CSK4 is a synthetic triacylated lipoprotein signaling through TLR1/2 [8] . TLR3 recognizes double-stranded RNA along with its synthetic analog, polyinosinedeoxycytidylic acid (Poly I:C) [5] . Stimulation of TLR2, TLR3, or TLR4 signaling pathways results in activation of a series of signaling proteins leading to expression of pro-inflammatory cytokine and chemokine genes [9] . These cytokines and chemokines contribute to the complex inflammatory milieu of sepsis.
Heterotrimeric guanine nucleotide binding regulatory (G) proteins of the G inhibitory class (G i ) are involved in signaling to microbial stimuli. Our recent studies demonstrated that Gα i proteins were directly activated by LPS [10] . Inhibition of Gα i protein with pertussis toxin (PTx) augments LPS-induced inflammation in vitro and in vivo [11] [12] [13] [14] . In addition to pharmacologic inhibition of Gα i protein, mice with genetic deletion of Gα i2 protein exhibit an enhanced inflammatory response and reduced survival in response to cecal ligation and puncture-induced sepsis [10] . Collectively, these findings suggest an antiinflammatory role of Gα i proteins in inflammatory response.
Since inhibition of Gα i protein augments the inflammatory response, we hypothesized that increased Gα i protein function or overexpression of Gα i protein will suppress TLR-induced inflammation. WT and novel transgenic mice with genomic knock-in of an RGS-insensitive Gα i2 (GS/GS) were employed [15] . The TLR4 ligand LPS, TLR2 ligand Pam3CSK4, and TLR3 ligand Poly (I:C)-induced tumor necrosis factor alpha (TNF-α), and interleukin (IL)-6 production in splenocytes, macrophage, and MEFs were determined. LPS shock induced plasma TNF-α, and IL-6 production were assessed in GS/GS vs WT mice. In subsequent studies, Raw 264.7 cells stably expressing control vector and Gα i2 proteins were generated. LPS-and Pam3CSK4-induced TNF-α and IL-6 production were determined. Collectively, these demonstrate an anti-inflammatory function of Gα i2 proteins in regulating TLR-induced inflammatory response.
MATERIALS AND METHODS

Mice
Gα i2
G184S/G184S (GS/GS) mice and littermate WT mice with C57BL/6 background were generated by breeding heterozygous mice as described previously [15] . Studies employed 7-to 9-week-old GS/GS and age-matched WT mice. The gain of function Gα i2 G184S/ G184S mice were obtained from Dr. Richard R. Neubig (University of Michigan). The investigations conformed to the Guide for the Care and Use of Laboratory Animals published by the National Institutes of Health and operated under the approval of the institutional animal care and use committee.
Raw Gα i2 Cell Line
WT human Gα i2 gene was cloned into a ViraPower Lentiviral Expression System using pLenti6/ V5 directional TOPO cloning kit. A pLenti6/V5-GW/ lacZ plasmid was used as a control plasmid. Lentivirus containing Gα i2 and control vector were generated following manufacture's instructions (Invitrogen). Raw 264.7 cells were transduced with lentivirus and selected by Blasticidin to generate the Raw cell lines stably expressing Gα i2 and β-galactosidase. Since the pLenti6/V5 vector contains a V5 tag sequence, a V5 antibody was used to detect the overexpression of target protein. A representative Western blot shows the overexpression of Gα i2 and β-galactosidase in Raw cell lines (Fig. 1) . 
Cell Culture and Stimulation
RAW 264.7 cells stably expressing Gα i2 and β-galactosidase were grown in Dulbecco's modified Eagle's medium (Gibco Invitrogen Corporation, Carlsbad, CA) supplemented with heat inactivated 10 % fetal bovine serum (Cellgro Mediatech, Inc., Herndon, VA), 2 % penicillin/streptomycin (BioWhittaker, Inc., Walkersville, MD) and 2 ug/ml Blasticidin (Invitrogen) in 150 cm 2 tissue culture flasks and maintained at 37°C in 5 % CO 2 , 95 % air. The confluent cells were detached using 0.05 % trypsin-EDTA (Gibco Invitrogen Corporation, Carlsbad, CA) and passaged every 2-3 days. RAW 264.7 cells within 20 passages were used for experiments.
RAW 264.7 cells expressing Gα i2 and β-galactosidase were stimulated with LPS (10 ng/ml, ultra-pure LPS from Escherichia coli O111:B4, List Laboratories, Campbell, CA), Pam3CSK4 (1 μg/ml, InvivoGen), or Poly (I:C) (10 μg/ml, InvivoGen) for 24 h. LPS-induced TNF-α and IL-6 production were analyzed by enzymelinked immunosorbent assay (ELISA).
Peritoneal macrophages, splenocytes, and MEFs were isolated from GS/GS mice and littermate WT mice as previously described [10, 16, 17] and maintained in RPMI 1640 medium (Cellgro Mediatech, Inc., Herndon, VA), supplemented with heat inactivated 1 % fetal calf serum (Sigma, St. Louis, MO), 50 U/ml penicillin, 50 μg/ml streptomycin (Cellgro Mediatech, Inc., VA). The macrophages (1×10 6 cells/well) were incubated at 37°C for 2 h. Non-adherent cells were washed off. Typically, more than 95 % of macrophages were obtained as examined by stain with fluorescein isothiocyanate-conjugated anti-mouse F4/80 antibody (Caltag) and analyzed by flow cytometry. Macrophages were stimulated with 10 ng/ml of LPS, 1 μg/ml of Pam3CSK4, and 10 μg/ml Poly (I:C) for 24 h. Splenocytes (5×10 6 cells/well) in 24-well plates were stimulated with 10 ng/ml of LPS, 1 μg/ml of Pam3CSK4, and 10 μg/ml Poly (I:C) for 24 h. MEFs were stimulated with LPS (10 ng/ml) for 24 h. The supernatants were collected for assay of mediator production.
Endotoxemia
Endotoxemia was induced by intraperitoneal injection of LPS (25 mg/kg). Six hours later, plasma was taken for TNF-α and IL-6 measurements.
Western Blot
The Raw cells expressing Gα i2 and β-galactosidase were washed and lysed with ice-cold RIPA lysis buffer (10 mM Tris, pH 7.4, 1 % Triton X-100, 150 mM NaCl, 1 mM EGTA, 1 mM EDTA, 1 mM phenylmethylsulfonyl fluoride, 1 μg/ml aprotinin, 1 μg/ml leupeptin, and 1 μg/ml pepstatin A). The supernatant was collected and stored at −20°C until Western blot analysis.
For Western blotting, lysates were added to Laemmli sample buffer and boiled for 4 min. Subsequently, protein from each sample was subjected to 12 % sodium dodecyl sulfate-polyacrylamide gel electrophoresis and transferred onto a polyvinylidene difluoride membrane. The membranes were washed with Trisbuffered saline-Tween 20 (TBST) (20 mM Tris, 500 mM NaCl, and 0.15 % Tween 20) and blocked with 5 % milk in TBST (20 mM Tris, 500 mM NaCl, and 0.1 % Tween 20) for 1 h. After being washed twice with TBST (20 mM Tris, 500 mM NaCl, and 0.1 % Tween 20), membranes were incubated with polyclonal anti-V5 antibody (Invitrogen) overnight at 4°C. The membranes were washed twice with TBST (20 mM Tris, 500 mM NaCl, and 0.1 % Tween 20) and incubated with HRPconjugated secondary antibody in blocking buffer for 1 h. After being washed three times with TBST (20 mM Tris, 500 mM NaCl, and 0.15 % Tween 20), immunereactive bands were visualized by incubation with ECL plus detection reagents (GE Healthcare) for 5 min and were exposed to ECL Hyperfilm (GE Healthcare). The densitometry of bands was quantified with an NIH image software.
Assay for TNF-α and IL-6 Production
TNF-α and IL-6 production were measured using an ELISA with mouse TNF-α or IL-6 ELISA kits (eBioscience, San Diego, CA).
Statistical Analysis
Data are expressed as the mean±standard error of the mean. Statistical significance was determined by analysis of variance with Fisher's probable least-squares difference test or Student'st test using GraphPad Prism software. A p<0.05 value was considered statistically significant.
RESULTS
Gain of Function of Gα i2 Suppresses LPS and
Pam3CSK4-Induced TNF-α and IL-6 Production in Macrophage. Peritoneal macrophages were isolated from WT and GS/GS mice and stimulated with the TLR4 ligand LPS, TLR2 ligand Pam3CSK4, and TLR3 ligand Poly (I:C) for 24 h. LPS and Pam3CSK4-induced TNF-α (Fig. 2a) and IL-6 (Fig. 2b ) production were decreased (33±3 % and 46±4 %; 69±7 % and 58±16 %, respectively; p<0.05) in GS/GS mice compared with WT mice. Poly (I:C)-induced TNF-α and IL-6 production was not different between GS/GS mice with WT mice (Fig. 2a, b) .
Gain of Function of Gα i2 Decreases LPS and Pam3CSK4-Induced IL-6 but not TNF-α Production in Splenocytes.
Splenocytes were isolated from WT and GS/GS mice and were stimulated with LPS, Pam3CSK4, and TLR3 ligand Poly (I:C) for 24 h. There was no difference between WT and GS/GS mice in LPS and Pam3CSK4-induced TNF-α production in splenocytes (Fig. 2c) . However, LPS and Pam3CSK4-induced IL-6 production was decreased (64±13 % and 70±4 %, respectively; p<0.05) in GS/GS mice compared with WT mice (Fig. 2d) . Poly (I:C)-induced TNF-α and IL-6 production was not different between GS/GS mice with WT mice (Fig. 2c, d ).
Gain of Function of Gα i2 Inhibits LPS-Induced IL-6
Production in MEFs. Mouse embryonic fibroblasts (MEF) were isolated from WT and GS/GS mice and Fig. 3 . Effect of gain of function of Gα i2 protein on LPS-induced IL-6 production in MEF. MEFs were isolated and cultured from WT and GS/GS mice and stimulated with LPS and Pam3CSK4 for 24 h. LPSinduced IL-6 production was determined by ELISA. *p<0.05 compared to basal group; # p<0.05 compared to WT group. N=6. were stimulated with LPS for 24 h. LPS-induced IL-6 production in MEFs was decreased (65±2 %, p<0.05) in GS/GS mice compared with WT mice (Fig. 3) .
Gain of Function Gα i2 Mice Exhibit Decreased Plasma IL-6 Production Compared to Wild-Type Mice in Response to
Endotoxemia. WT and GS/GS mice were subjected to endotoxemia. In GS/GS mice, LPS-induced plasma TNF-α was not significantly different from WT mice (Fig. 4a) . However, LPS-induced IL-6 production was significantly decreased (60±10 %, p<0.05, Fig. 4b ) in GS/GS mice compared to WT mice.
Overexpression of Gα i2 Protein Decreases LPS and Pam3CSK4-Induced TNF-α and IL-6 Production in Raw Cell
Lines. The lentiviral expression system was used to generate Raw 264.7 cells that stably overexpressed Gα i2 protein (Raw Gα i2 ) and β-galactosidase (Raw-control vector). LPS-and Pam3CSK4-induced TNF-α and IL-6 production were determined by ELISA. The Raw Gα i2 cells exhibited decreased TNF-α (27±5 % and 25±1 %, respectively; p<0.05, Fig. 5a ) and IL-6 (39±0.4 % and 52±3 %, respectively; p<0.05; Fig. 5b ) production in response to LPS and Pam3CSK4.
DISCUSSION
These studies provide the first evidence that gain of function of Gα i2 protein suppresses LPS-and Pam3CSK4-induced inflammatory cytokines. We found that TLR4 ligand LPS-and TLR2 ligand Pam3CSK4-induced TNF-α and IL-6 production were decreased in peritoneal macrophages and IL-6 in splenocytes from gain of function of Gα i2 mice. Gain of function of Gα i2 protein also inhibited LPS-induced IL-6 production in MEFs. LPS-induced plasma IL-6 production was decreased in gain of function of Gα i2 mice compared to WT mice. The response of Raw 264.7 cell lines overexpressing Gα i2 protein to TLR2 and TLR4 ligands also supports the notion that Gα i2 protein suppresses TLR2 and TLR4 ligand-induced inflammatory cytokines.
Our previous studies and others' demonstrated that mastoparan (MP)-7, which activates Gα i proteins, reduces LPS-induced inflammatory responses in vitro Fig. 4 . Effect of gain of function of Gα i2 protein on LPS-induced plasma TNF-α and IL-6 production in mice. WT and GS/GS mice were subjected to endotoxemia for 6 h, and LPS-induced plasma TNF-α (a) and IL-6 (b) production were determined. *p<0.05 compared to basal group; # p<0.05 compared to WT group. N=4-6. and in vivo [10, 12, 14] . Lentschat et al. demonstrated that MP-7 differentially regulates TLR2 and TLR4 activation [11] . In contrast to MP-7, pretreatment with PTx, which inhibits Gα i proteins, significantly augments LPS-induced inflammatory cytokines in vivo, whereas PTx without LPS also did not induce an inflammatory response [10] . However, a limitation of MP-7 or PTx is that it is not Gα i isoform specific and, as with any pharmacologic agent, may have other effects. Our current studies employing isoform-specific targeting suggest that Gα i2 protein regulates both TLR2 and TLR4 signaling. We also employed TLR3 ligand Poly (I:C) in our studies. Interestingly, we found that Poly (I: C) induced only modest TNF-α and IL-6 production in macrophage and splenocyte from WT mice. Gain of function of Gα i2 proteins exhibited no effect on Poly (I: C)-induced TNF-α and IL-6 production. Similar results were observed when Gα i2 proteins were overexpressed in Raw 264.7 cells and the cells were stimulated with TLR ligands. Since both TLR2 and TLR4 activate MyD88 signaling and TLR3 activates Toll-IL-1 receptor domain-containing adaptor inducing interferon-β(TRIF) signaling [5] , these data suggest that Gα i protein may only regulate MyD88 dependent signaling and has no effect on TRIF dependent signaling in macrophages and splenocytes. The mechanism by which Gα i proteins inhibit TLR-induced inflammation is being intensively investigated. Our previous studies demonstrated that a Gα i2 minigene plasmid or dominant negative Gα i3 blocked TLR4-induced ERK1/2 activation in HEK293 cells [13] . In endothelial cells, PTx suppressed ERK 1/2, and AKT induced by TLR activation independent of tumor necrosis factor receptor-associated factor 6 [14] . Both ERK 1/2 and PI3 kinase-induced signaling may have anti-inflammatory effects [18, 19] .
It has been demonstrated that TLR4 clusters with multiple receptors upon LPS stimulation [20] . For example, the G protein coupled receptor (GPCR) CXCR4 which is coupled to Gi protein has been postulated as a co-regulator of TLR4 [20] . Blocking antibodies to CXCR4 increases TLR4 activation, whereas a CXCR4 ligand reduces TLR4 activation [21, 22] . Also, in Raw 264.7 cells, we have demonstrated that LPS directly activates Gα i proteins determined by an increase in active Gα i -GTP complex [10] . Thus, TLR receptors may directly activate Gα i proteins perhaps through a consensus motif for binding Gα i in the TLR intracellular domain [14, 23] . Alternatively but not exclusively, ligand binding to TLRs may indirectly activate Gα i proteins through transactivation of GPCRs or through autocrine pathways, e.g., CXCR4 ligands [14, 22] . Thus, activation of Gα i signaling may constitute a novel negative feedback to limit TLR-induced inflammation. Our findings that gain of function of Gα i2 in cells and mice and that overexpression of Gα i2 supress TLR2 and TLR4 activation are consistent with such a hypothesis.
